Andrew R Marks

7PUBLICATIONS
36CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Autonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 04, 2025
L-Type Cav1.3 and HCN Channels Mediate Heart Rate Acceleration by Catecholamines.

Eleonora Torre, Mélanie Faure, Isabelle Bidaud

|Sep 29, 2025
Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.

Gabriel Redel-Traub, Steven O Marx, Andrew R Marks

|Aug 28, 2025
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data.

Alexander Chang, Halil Beqaj, Leah Sittenfeld

|Jun 13, 2025
Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders.

Marco C Miotto, Estefania Luna-Figueroa, Carl Tchagou

|Sep 27, 2023
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice.

Yang Liu, Steven Reiken, Haikel Dridi

Pageof 2